Marker Therapeutics Other Equity Adjustments (Quarterly) Analysis

Marker Therapeutics, Inc. (MRKR)

1.63 +0.16 (+10.88%) USD | NASDAQ | Feb 24, 16:00

1.58 -0.05 (-3.07%) After-Hours: 04:04

View Other Equity Adjustments (Quarterly) for MRKR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Equity Adjustments (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Equity Adjustments (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Equity Adjustments (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	--
Viridian Therapeutics, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Kiniksa Pharmaceuticals International Plc	Upgrade
Neurocrine Biosciences, Inc.	Upgrade